News

Sacrifices, trade-offs behind big win, says Glenmark’s Saldanha
Glenmark’s outlicensing deal with AbbVie for a novel drug for blood cancer under development sets a new course for the ...
The American Journal of Managed Care5h
FDA Reviewing Sotatercept-csrk Label Expansion for PAH
Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
FDA grants Zenith's ZEN-3694 Fast Track Status
Zenith Epigenetics Announces Grant of U.S. Food and Drug Administration Fast Track Designation for ZEN-3694 in NUT Carcinoma Calgary, Alberta--(Newsfile Corp. - July 14, 2025) - Zenith Epigenetics Ltd ...
Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
Opinion
How Hong Kong’s new drug regulator can give the city a competitive edge
Readers discuss the potential of the Centre for Medical Products Regulation, and the struggles of fast-food chains Feel strongly about these letters, or any other aspects of the news? Share your views ...
Stocktwits on MSN14h
Crinetics Pharma’s Oral Drug Shows Lasting Relief For Acromegaly Patients In Latest Study; Retail Buzz Builds
Retail chatter around Crinetics Pharmaceuticals picked up late Sunday after the company released long-term data for its oral ...